First Trust NYSE Arca Biotechnology Index Fund
FBT
188 hedge funds and large institutions have $744M invested in First Trust NYSE Arca Biotechnology Index Fund in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 83 reducing their positions, and 51 closing their positions.
127% more call options, than puts
Call options by funds: $1.56M | Put options by funds: $687K
15% less funds holding
Funds holding: 222 → 188 (-34)
16.83% less ownership
Funds ownership: 60.47% → 43.64% (-17%)
40% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 83
58% less capital invested
Capital invested by funds: $1.77B → $744M (-$1.03B)
63% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 51
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$24.8M |
| 2 |
JP Morgan Chase
New York
|
+$5.62M |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$3.26M |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$2.66M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$578M |
| 2 |
Morgan Stanley
New York
|
-$80M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$60.8M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$27.8M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$26.3M |
FBT Hedge Fund Activity: Q3 2019 in Review
188 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2019, worth a combined $744M — down 58% from $1.77B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of FBT and 19 opened new positions — a net loss of 32 holders — while 83 trimmed existing stakes and 50 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $24.8M. The largest seller was First Trust Advisors, exiting entirely with an estimated $578M sold.
- 188 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2019, down from 222 in Q2 2019.
- Funds reported $744M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2019, down 58% quarter-over-quarter.
- 19 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2019 and 51 closed out, a net change of -32 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2019 was Millennium Management, an estimated $24.8M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2019 was First Trust Advisors, an estimated $578M sold.
Based on aggregated 13F filings for Q3 2019.